Reckitt Sells Russian Hygiene Business, Completing Its Market Exit

What Reckitt's Russian Asset Sale Changed

Reckitt has agreed to sell its remaining hygiene products business in Russia, according to a report from marketscreener.com. The sale draws a line under a process that started in 2022, when Reckitt, the maker of Dettol and Durex, said it would scale back its presence in the country alongside dozens of other Western consumer companies. Reckitt has not published the financial terms of the deal.

Why Reckitt RKT Stock Is in Focus

Reckitt has spent the past few years simplifying a business that stretches across health, hygiene and nutrition brands in more than 60 countries. Russia has been a small but awkward part of that footprint, too small to matter much to group revenue, but large enough to draw scrutiny from investors, campaigners and regulators uneasy about Western companies still trading there. Selling the unit removes that overhang. It also fits a broader pattern at Reckitt of trimming non-core or higher-risk operations to focus management attention and capital on its biggest brands, from Nurofen to Finish.

Which Stocks, and Why

The direct effect is on Reckitt. A full exit from Russia takes a small revenue stream off the books, so there could be a modest, one-off hit to reported sales in the region the business used to serve. Against that, the company sheds compliance costs, currency risk from the rouble, and the reputational exposure of continuing to operate in a market under Western sanctions. For a group of Reckitt's size, a single national hygiene unit is not a swing factor for earnings, so the practical effect on group profit is limited. The more meaningful part of the story is qualitative, one less item on the list of why-is-this-company-still-there questions that institutional investors and ESG focused funds have been asking consumer goods companies since 2022.

No other company in the London market has a comparable direct stake in this specific transaction. The story does not point to a wider sector effect, since Reckitt's remaining Russian footprint was already unusual among its FTSE peers, most of which exited far earlier.

What to Watch

Investors should watch for any disclosure of the sale price or any associated write-down in Reckitt's next results statement, since a loss on disposal, if material, would show up as an exceptional item rather than a hit to underlying trading profit. It is also worth checking whether Reckitt confirms this as its final Russian divestment or whether smaller residual operations remain. Beyond that, the more useful gauge of Reckitt's health remains its underlying volume and pricing trends in its core hygiene and health categories, which this disposal does not change.